 Research
 Open access
 Published:
Analytic approach to explore dynamical osteoporotic bone turnover
Advances in Difference Equations volumeÂ 2019, ArticleÂ number:Â 61 (2019)
Abstract
Background
The dynamics of the osteoporotic bone turnover is studied in this paper with the aid of stability analysis of the associated mathematical model. Osteoporosis, which is a common bone disorder, is studied in this papper in detail with an emphasis on the relative threshold values. We examine the expository signaling among the bone cells named osteoclast and osteoblast. Main functioning of osteoblasts is bone formation, whereas osteoclasts are bone removal cells.
Methods
Mathematical framework for osteoporotic bone turnover comprising of the communication between osteoclasts and osteoblasts has been presented to exhibit the conditions for stability in bone turnover.
Results
The percentage ratios of the population of osteoblasts/osteoclasts have been determined via numerical simulations. The remedial upshots of targeting osteoporotic cells participating in such process are examined.
Conclusions
From our analysis we have conclude that the role of external agents in treating the diseased bone can be better interpreted with the aid of a theoretical model.
1 Introduction
The bone formation and resorption is a continuous process and is known that collagen strands and lifeless bone minerals cover about 60â€“70 percent of the area of a bone at a local site, whereas the remaining proportion carries water. An infant body contains 270 bones, whereas an adult skeleton is made of 260 bones, which happens due to the continuous process of bone resorption and formation. There are two forms of bones, called cortical and trabecular (also known as cancellous). A cortical bone is an external layer of bone, which is hard and thick, whereas a spongy and soft structure lying inside the bone is called a trabecular bone. The main functioning of the bone includes the support to body and provides the base to marrow. There are numerous kinds of bone cells, but mainly two cells, named osteoclast (C) and osteoblast (B), take part in the functioning and maintenance of a bone. The main activity of osteoclast includes the resorption of mineralized tissues, whereas osteoblasts are boneforming cells. Osteocytes are bone cells lying at the deep rooted area of a bone.
A bone guarantees redesigning for the duration of whole life in spatially and transiently discrete destinations in an organized procedure including resorption, trailed by formation of a new bone [19]. Bone remodeling is accountable for development and mechanically instigated adaptation of bone and entails the processes of bone formation and resorption, however, globally correlated, takes place separately at anatomical different sites. Such a tightly correlated event needs harmonized activities of multicellular components to confirm that bone removal and making take place successively at the identical anatomical place to preserve the bone volume.
The two cells mainly responsible for bone remodeling process are osteoclasts (C) and osteoblasts (B). The key role of both kinds of cells is quite opposite; osteoclasts are boneresorbing cells, whereas osteoblasts function as boneforming cells. Osteoclasts are lethally differentiated myeloid multinucleated osteoclast precursors, which are exclusively transformed to eradicate mineralized bone milieu. Precursors of osteoclasts flow in the blood, and bone marrow and adult osteoclasts are produced from synthesis of the precursors. Such an evolution takes place after the signaling through receptor activators of NFÎºÎ² and its ligand. During bone resorption, osteoclasts append to the bone and develop tight seals with the underlying bone matrix in roughly circular extensions of their cytoplasm, and within these sealed zones, they form ruffled border membranes. By this sealing and secretory means the bone matrix is concurrently degraded, and bone minerals are dissolved while protecting neighboring cells from the harmful effects of HCl. Osteoblasts are mononucleated cellular units derived from osteoblast precursors. They are responsible for manufacturing of the major proteins of bone and type 1 collagen like osteocalcin and osteopontin, which compile the organic milieu of bone. These cells are also accountable for the mineralization of bone and fabricate enzyme alkaline phosphates. Recent investigations exhibit the role of osteoblasts as an imperative component in governing osteoclastogenesis. Another type of bone cells namely osteocytes, a latent state of osteoblasts, also participate in bone maintenance and mineralization. Many therapies of different bone disorders affect through osteocytes.
Various growth factors give paracrine coupling amongst C and B and additionally autocrine cycles for positive and negative input control of every cell kind. Among the most essential components, there are the proresorptive cytokine receptor activator of nuclear factor Î² ligand (RANKL) and its decoy receptor osteoprotegerin (OPG), which are communicated by B and corresponding control of C [17, 24]. Complex formation of OPG and RANK with RANKL give anabolic and catabolic effects on bones, respectively. Several other elements like transforming growth factorÎ² (TGFÎ²) and parathyroid hormone (PTH) also incorporate in such phenomena.
Multiple and dispensable activities of TGFÎ² family incorporate monitoring of various characteristics and outcomes of cell functions, including growth, prolifiration, and dispersal, in all organisms of the human body. TGFÎ² plays a vital role in administrating the perpetuation of bone metabolic homeostasis [18]. TGFÎ² is discharged and enacted by resorbing osteoclasts and gives an anabolic effect on a bone by directly influencing the osteoblasts [3, 7]. Although TGFÎ² directly takes part in the emergence of osteoclasts during the latent state of osteoblasts, it hinders bone removal by diminishing the expression of RANKL on osteoblasts [23].
PTH employs typical actions on bone metabolism by triggering its receptor on target cells. Its main functioning includes calcium regulation. PTH has dual effects on bone turnover process. Constant exposure to PTH gives a negative feedback, whereas a sporadic contact to low quantity of PTH is coupled with positive effects. A number of studies have been conducted to investigate the effect of PTH drug in dysregulated bone remodeling and showed anabolic effects on bones.
Sclerostin, encrypted by SOST gene, is an extravasated glycoprotein expressed by osteocytes [4, 28, 29]. It is a Cterminal cysteine knotlike (CTCK) domain and has resemblance to the DAN family of bone morphogenetic protein (BMP) antagonists. Animalâ„¢ models have been found potentially valuable for investigating sclerostin for the reason that they have high conservancy over vertebrates (the percentages of the sequences of amino acids measured in the mouse and rate are 88 and 89, respectively, which are quite similar to human sequences) [4]. Binding of sclerostin to its coreceptors expressed on the surface of osteoblasts constrains the WntÎ²catenin signaling [14] and, consequently, suppresses differentiation, production, and undertakings of osteoblastic cells [2]. Experimental study on SOST knockout mice showed high levels of bone mass phenotype [15], whereas the results were rather contrasting, i.e., a lowmass phenotype was observed in a transgenic mice with an overexpression of SOST gene [12]. Therefore, osteoblast movement is selfsynchronized by a negative feedback setup.
Poroelasticity is the study based on the relation among deformation and fluid flow in a fluid drenched malleable medium [6]. The main activities of bone fluid include the transportation of nutrients to cells engrossed in medium and moving waste of cells away. It also provides minerals to bone tissue for relocation. A mechanosensory system of bone and bone fluid are strongly interconnected. A mechanical stress plays a vital role in supplying the bone fluid. A mechanical strain supports the bone deformation process, which in turn produces the fluid flow [20, 30]. Bone cells also get affected through such a mechanism of mechanical strain; it helps in maintaining the bone remodeling process. Many bone diseases like osteoporosis have been examined by applying a continuous mechanical stress; such a stress gave anabolic effects on bone formation, whereas catabolic affects bone resorption [8]. A disparity among RANKL/OPG signaling equipoise gives rise to several bone pathological processes, mostly associated with ageing, called osteopenia, and with more extremity, osteoporosis. Osteoporosis is a bonerelated disorder regarded as skeletal infirmity with low bone mineral density (BMD), which subsequently causes recurrent microharms and impulsive cracks; it is a persistent syndrome demanding longterm cure. Middleaged women and elderly people are the prime targets of osteoporosis, and currently its influence is intensely rising socially and economically; WHO has declared it as the second foremost healthcare issue. In a regular bone remodeling process, RANKL/OPG is prudently balanced; the rise in RANKL plays a vital part in supporting resorption via osteoclast development, activities, and persistence. As the human body gets older, the density of the osteons expands, and the cortical sponginess and architectural damages of bone also rise due to the execution of a large number of remodeling cycles. This scenario initiates a vicious cycle where microharms occur often, consequently weakening bone configuration and increasing proportion of impulsive fractures [31]. Furthermore, latest analyses on bone remodeling propose that plasma levels OPG and RANKL are contrariwise linked to BMD and take part in the growth of osteoporosis in postmenopausal women [9].
Recently, many researchers have developed several mathematical models of bone remodeling to study the deep dynamics of intracellular and intercellular mechanisms of bone. Some of the models allow just the estimation of cell population dynamics and alteration in bone density; the first attempt in this regard was by Komarova et al. [11], whereas some of them deal with several bone diseases including the tight coupling between bone cells and their potential therapies based on their efficacy, first introduced by Lemaire et al. [13]. Komarova et al. [11] model depicts that the dynamical behavior of bone remodeling strictly depends on the regulation of bone resorbing cells by autocrine factors, and the osteoclastâ€“osteoblast communication produces a complex nonlinear structure, which cannot be figured out from the analysis of each cell class alone. Many researchers extended the model of Komarova et al. afterward. Ayati et al. [1] developed a model to study myeloma bone disorder and demonstrated how therapeutic strategies might be examined through such computational systems. ChenCharpentier and Diakite [5] introduced delays in the model of Komarova et al. [11] and checked the stability and bifurcation. Ryser et al. [25] developed a mathematical model based on partial differential equations with time delays to simulate the dynamics of bone multicellular units. Their system illustrates the RANKL/OPG signaling pathway along with osteoclastâ€“osteoblast communication. Lemaire et al. [13] proposed a mathematical framework comprising of cellular control and biochemical feedbacks systems responsible for the modulation of bone remodeling. Their model also incorporates simulation of the growth of several metabolic disorders such as osteoporosis, estrogen dearth, or vitamin D deficiency and determines possible treatments based on their effectiveness. Since RANK/RANKL/OPG signaling pathway is a main signaling cascade synchronizing bone turnover, practical insinuation of particular RANKL/OPG expression profiles on bone density were profoundly investigated by Pivonka et al. [21]. They developed a model comprising of the dynamics of bone cellular units, based on the work of Lemaire et al. [13] integrating the RANK/RANKL/OPG pathway along with the modulating effect of TGFÃŽ^{2} on bone cells. Pivonka et al. [22] for the first time introduced a PK model of drug denosumab along with a PD model of bone remodeling and analyzed the effect of denosumab on osteoporosis through this PK/PD model.
2 Mathematical models
2.1 Osteoporotic model
Here we describe a simplified version of LiÃ²â€™s model [16] to depict the temporal variations in osteoclasts (C) and osteoblasts (B) cell concentrations during an osteoporotic bone turnover. We make the following assumptions by taking into account the dysregulated bone remodeling process defined in the previous section.

1.
The number of osteoclasts (osteoblasts) includes the populations of osteoclasts (osteoblasts) precursors and osteoclasts (osteoblasts).

2.
The death rate of bone resorbing and boneforming cells is proportional to the present populations of that particular cell.

3.
As the ageing factor (\(a_{\mathrm{ageing}}\)) plays a crucial role in the development of osteoporosis and weakens the bones by destroying the bone cells, this effect has been included in bone removal and forming bone cells.

4.
No external effects have been included in the population system.
Based on these assumptions, the following model gives a more general view of temporal changes in both bone cells concentrations:
where C and B represent the populations of bone resorbing and bone forming cells, respectively, \(a_{i}\); \(i=1,2\) are the proliferation rates of osteoclasts and osteoblasts precursors, respectively, and \(b_{i}\); \(i=1,2\) are the apoptosis rates of C and B, respectively. The function \(g_{i}(C,B)\); \(i=1,2\) illustrates the communication between C and B depending on the autocrine and paracrine factors involved in the growth rate of both cells.
Now considering the function \(g_{i}(C,B)\); \(i=1,2\) in a power law approximation form provided in [16], our system (1) takes the following form:
The parametric values are listed in TableÂ 1.
In system (2), \(\delta_{ij}\); \(i,j=1,2\) represents the net effect of several growth factors participating in bone turnover process and producing autoregulations in osteoclasts and osteoblasts or effecting one cell type through the other. We supposed that the quantity of these growth factors depend on the donor cells population at any instant. The brief description of \(\delta_{ij}\); \(i,j=1,2\) is as follows:

\(\delta_{11}\), net effect of osteoclasts autocrine factors,

\(\delta_{21}\), osteoblastsreleased paracrine factors influencing osteoclasts,

\(\delta_{12}\), osteoclastsreleased paracrine factors influencing osteoblasts,

\(\delta_{22}\), net effect of osteoblasts autocrine factors.
Due to an imbalance in bone turnover practice in an osteoporotic bone, a disruption in OPGRANKL complex formation occurs, which influences the paracrine effect produced by osteoblasts on osteoclasts. To incorporate this aspect, a supplementary factor (\(\delta_{OL}\)) has been added in the model. A change in bone density (Y) occurs as the C and B concentrations exceed their steadystate level; this aspect is described by the equation
In (3), the steadystate values of C and B are represented, and \(s_{i}\); \(i=1,2\) are the normalized activities of bone resorption and formation, respectively.
A numerical evidence of system (2) along with Eq.Â (3) is provided in [16]. In this paper, a theoretical analysis of this system has been conducted to provide the evidence of the existence of a periodic solution. We modify system (2) by making the following assumptions:

\(C^{\delta_{11}}\propto C\) and \(B^{\delta_{22}}\propto B\)

\(\delta_{1}=\delta_{21}\) and \(\delta_{2}=\delta_{12}\), where \(\delta _{i}\), \(i=1,2\), represent the paracrine effects produced by RANKRANKLOPG signalling pathway and other factors including PTH and TGFÎ². In addition, the effect of \(\delta_{1}\) is catabolic as it represses the concentration of osteoclasts, whereas \(\delta_{2}\) stimulates the production of osteoblasts and so produces an anabolic effect on osteoblasts population.
So, based on these assumptions, system (2) takes the following form:
2.2 Theoretical investigation of the model
The theoretical investigation helps to understand the model dynamics [10, 26, 27]. The schematic (Fig.Â 1) depicts the role of osteoclast precursors, active osteoclasts, osteoblasts, and RANKRANKLOPG signaling pathway during the osteoporosis. We will study the qualitative aspects of system (4) only, as Eq.Â (3) is decoupled from the system. Let \(( C_{0},B_{0})\) be the initial condition of the system. Then a unique solution of (4) exists if \(\delta_{1}+\delta_{OL},\delta_{2}\geq 0\) and \(C_{0},B_{0}>0\). It is easy to see that (4) can be written as
which gives the following solution:
By setting \(\frac{dC}{dt}=\frac{dB}{dt}=0\), following steady states have been obtained: \((0,0)\) if \(\delta_{1}+\delta_{OL},\delta_{2}\geq 0\) and
which always exists. The jacobian of (4) around the steady state \(( C,B)\) is
The eigen values evaluated at the equilibrium poin \(( C,B)\) have a vanishing real part only if \((\delta_{1}+\delta_{OL})\delta_{2}\leq 0\), which a gives a unique positive periodic solution of (4). In the next theorem, the oscillatory behaviour of the nonlinear system (4) is shown.
Theorem 1
A unique positive oscillatory solution of nonlinear system (4) exists subjected to positive initial conditions and the property \((\delta_{1}+\delta_{OL})\delta_{2}\leq 0\).
Proof
System (4) implies
which after integration yields
where C represents the constant of integration. We define a new variable z as follows:
Also, we have
where K is the constant of integration. To investigate the behaviour of \(z(C,B)\), we consider the condition \((\delta_{1}+\delta_{OL})\delta_{2}\leq 0\). In particular, let \(\delta_{1}+\delta_{OL}<0\). This implies that, as \(B\rightarrow0\) and \(B\rightarrow\infty\), we have \(z\rightarrow0\), whereas as \(C\rightarrow0\) and \(C\rightarrow\infty\), we have \(z\rightarrow\infty\). Now we determine the firstorder derivative of z w.r.t. C:
A similar argument is obtained for \(\frac{dz}{dB}\). It is clear that \(\frac{dz}{dC}=\frac{dz}{dB}=0\) at the equilibrium point \(( C,B)\) is given in (7). The behavior of the function z is depicted in Fig.Â 2. It is easy to see that, as \(z\rightarrow0\), B exists, but C vanishes. As B increases, it intersects just one value of C. A further increment in the value of B gives intersection with two values of C. We have a similar scenario for C over B. It gives a closed curve in CBphase plane where \(B=B(C)\). Hence the solution of (4) is oscillatory and positive.
â€ƒâ–¡
2.3 External agents influencing the osteoporotic bone turnover
In (5), system (4) has been modified by including an external effect, produced by osteocytes, as a consequence of a mechanical strain applied. Such an effect has been depicted in the form of a function \(\gamma(t)\) that counts the RANKL produced by osteocytes along with its regulation by Sclerostin inhibition. So system (4) takes the following form:
where \(d_{1}\) represents the proportionality constant. At present, no precise functional form of \(\gamma(t)\) is constructed, so we assume a consistent input of osteoclasts and investigate the stability of the following system:
2.3.1 Stability analysis of the model
Assume \((C_{0},B_{0})\) to be the initial conditions of system (6); \(C_{0},B_{0}\geq0\), for \((\delta_{1}+\delta_{OL})\delta_{2}<0\), the system has a unique positive solution. The first equation of system (6) takes the following form:
which gives
The second equation of system (6) implies
The following unique steady state has been obtained by setting \(\frac{dC}{dt}=\frac{dB}{dt}=0\).
The jacobian matrix of (6) is computed as follows:
\(\operatorname{tr}(J( C,B)=0)\) and \(\operatorname{Det}(J( C,B)>0)\) at the nontrivial steadystate value \(( C,B)\); \((\delta_{1}+\delta_{OL})\delta_{2}\leq0\). So, dynamically, we have a probable fulcrum for the system. Dulacâ€™s criterian has been implemented to show the nonexistence of the oscillatory solutions for system (6).
Theorem
The nonlinear system (6) with the initial condition \((C_{0},B_{0})\), provided that \(C,B>0\) and \((\delta_{1}+\delta_{OL})\delta_{2}\geq0\), exhibits a positive solution, which shows affinity toward the stable equilibrium solution \(( C,B)\).
Proof
We consider the domain \(\varGamma=R^{+}\times R^{+}\), a simply connected region of the 2Dplane, and the function \(f(C,B)= \frac{1}{CB}\) is continuously differentiable on Î“. Assume that \(h(C,B)=B^{\delta_{1}+\delta_{OL}}(a_{1}C+ \frac{d_{1}}{C})a_{\mathrm{ageing}}b_{1}C\) and \(k(C,B)=a_{2}C^{\delta_{2}}Ba_{\mathrm{ageing}}b_{2}B\), it is easy to see that the functions \(h(C,B)\) and \(k(C,B)\) are equal to the righthand side of system (6). Then
As
is not equal to zero and does not switch sign in the region Î“, this implies the nonexistence of closed orbits in Î“.â€ƒâ–¡
3 Numerical simulations
The inspiration behind this scheme is that we can now solve the normalized boundary value problem, although nonlinear, quite easily, using both analytic and numerical schemes. The most widely employed numerical method for the boundary value problems is the collocation method. The advantage of this method is that it reduces the nthorder differential equation(s) into n firstorder differential equations, thus reducing the computational cost on a large domain with small step size and a range of parameters. We have simplified the three systems using the generalized collocation method (GCM). Collocation methods are basically implicit Rungeâ€“Kutta quadrature techniques.
FiguresÂ 2, 3 and 4 presents the total bone mass and change in osteoblast relative to change in osteoclast for osteoporotic bone model (Eq.Â (2)) and for a model where the external agents (Eq.Â (6)) were taken into account. From Fig.Â 4 it is evident that the external agents influence the osteoclast and osteoblast activity and hence the osteoporotic bone mass. The external agent was incorporated into the model when the total bone mass was 6% lower than the actual bone mass (steady state) due to osteoporosis. From our numerical results (as shown from the inclination in total bone mass) we can depict that the external agent can be prescribed as an efficient therapeutic agent.
3.1 Conclusions and future work
In this paper, complex dynamics of bone diseases are studied with the aid of numerical experiments. The stability analysis is of great significance in the field of computational biology. It helps to validate the parametric values, the correct selection of thresholds values, which are useful during diseases diagnosis and therapeutics. In this paper, we have considered these factors with the aid of an extended model, where the external agent and its role as a therapeutic strategy are examined. In our future work, we aim to extend this study by interfacing it with clinical trials.
References
Ayati, B.P., Edwards, C.M., Webb, G.F., Wikswo, J.P.: A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease. Biol. Direct 5(1), 28 (2010)
Baron, R., Rawadi, G.: Targeting the wnt/Î²catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148(6), 2635â€“2643 (2007)
Bonewald, L.F., Dallas, S.L.: Role of active and latent transforming growth factor Î² in bone formation. J. Cell. Biochem. 55(3), 350â€“357 (1994)
Brunkow, M.E., Gardner, J.C., Van Ness, J., Paeper, B.W., Kovacevich, B.R., Proll, S., Skonier, J.E., Zhao, L., Sabo, P.J., Fu, Y.H., et al.: Bone dysplasia sclerosteosis results from loss of the sost gene product, a novel cystine knotcontaining protein. Am. J. Hum. Genet. 68(3), 577â€“589 (2001)
ChenCharpentier, B.M., Diakite, I.: A mathematical model of bone remodeling with delays. J. Comput. Appl. Math. 291, 76â€“84 (2016)
Cowin, S.C.: Mechanosensory Mechanisms in Bone. Lecture Notes â€“ ABIOMED (2001)
Erlebacher, A., Filvaroff, E.H., Ye, J.Q., Derynck, R.: Osteoblastic responses to TGFÎ² during bone remodeling. Mol. Biol. Cell 9(7), 1903â€“1918 (1998)
Haba, Y., Lindner, T., Fritsche, A., SchiebenhÃ¶fer, A.K., Souffrant, R., Kluess, D., Skripitz, R., Mittelmeier, W., Bader, R.: Relationship between mechanical properties and bone mineral density of human femoral bone retrieved from patients with osteoarthritis. Open Orthop. J. 6, 458 (2012)
Jabbar, S., Drury, J., Fordham, J.N., Datta, H.K., Francis, R.M., Tuck, S.P.: Osteoprotegerin, rankl and bone turnover in postmenopausal osteoporosis. J. Clin. Pathol. 64(4), 354â€“357 (2011)
Jerez, S., Chen, B.: Stability analysis of a Komarova type model for the interactions of osteoblast and osteoclast cells during bone remodeling. Math. Biosci. 264, 29â€“37 (2015)
Komarova, S.V., Smith, R.J., Dixon, S.J., Sims, S.M., Wahl, L.M.: Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. Bone 33(2), 206â€“215 (2003)
Kramer, I., Loots, G.G., Studer, A., Keller, H., Kneissel, M.: Parathyroid hormone (PTH)induced bone gain is blunted in sost overexpressing and deficient mice. J. Bone Miner. Res. 25(2), 178â€“189 (2010)
Lemaire, V., Tobin, F.L., Greller, L.D., Cho, C.R., Suva, L.J.: Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J. Theor. Biol. 229(3), 293â€“309 (2004)
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S.E., Wu, D.: Sclerostin binds to LRP5/6 and antagonizes canonical wnt signaling. J. Biol. Chem. 280(20), 19883â€“19887 (2005)
Lin, C., Jiang, X., Dai, Z., Guo, X., Weng, T., Wang, J., Li, Y., Feng, G., Gao, X., He, L.: Sclerostin mediates bone response to mechanical unloading through antagonizing wnt/Î²catenin signaling. J. Bone Miner. Res. 24(10), 1651â€“1661 (2009)
LiÃ², P., Paoletti, N., Ali Moni, M., Atwell, K., Merelli, E., Viceconti, M.: Modelling osteomyelitis. BMC Bioinform. 13(14), S12 (2012)
Hofbauer, L.C., Heufelder, A.E.: Role of receptor activator of nuclear factorÎºB ligand and osteoprotegerin in bone cell biology. J. Mol. Med. 79(5â€“6), 243â€“253 (2001)
Å‚ukasz, A., Poniatowski, Wojdasiewicz, P., Gasik, R., Szukiewicz, D.: Transforming growth factor beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators of Inflammation, 2015 (2015)
Parfitt, A.M.: Osteonal and hemiosteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell. Biochem. 55(3), 273â€“286 (1994)
Piert, M., Zittel, T.T., Becker, G.A., Jahn, M., Stahlschmidt, A., Maier, G., Machulla, H.J., Bares, R.: Assessment of porcine bone metabolism by dynamic [18F] fluoride ion PET: correlation with bone histomorphometry. J. Nucl. Med. 42(7), 1091â€“1100 (2001)
Pivonka, P., Zimak, J., Smith, D.W., Gardiner, B.S., Dunstan, C.R., Sims, N.A., Martin, T.J., Mundy, G.R.: Model structure and control of bone remodeling: a theoretical study. Bone 43(2), 249â€“263 (2008)
Pivonka, P., Zimak, J., Smith, D.W., Gardiner, B.S., Dunstan, C.R., Sims, N.A., Martin, T.J., Mundy, G.R.: Theoretical investigation of the role of the RANKâ€“RANKLâ€“OPG system in bone remodeling. J. Theor. Biol. 262(2), 306â€“316 (2010)
Quinn, J.M.W., Itoh, K., Udagawa, N., HÃ¤usler, K., Yasuda, H., Shima, N., Mizuno, A., Higashio, K., Takahashi, N., Suda, T., et al.: Transforming growth factor Î² affects osteoclast differentiation via direct and indirect actions. J. Bone Miner. Res. 16(10), 1787â€“1794 (2001)
Raisz, L.G.: Physiology and pathophysiology of bone remodeling. Clin. Chem. 45(8), 1353â€“1358 (1999)
Ryser, M.D., Komarova, S.V., Nigam, N.: The cellular dynamics of bone remodeling: a mathematical model. SIAM J. Appl. Math. 70(6), 1899â€“1921 (2010)
Tunc, C.: Uniformly stability and boundedness of solutions of second order nonlinear delay differential equations. Appl. Comput. Math. 10(3), 449â€“462 (2011)
TunÃ§, C., TunÃ§, O.: A note on certain qualitative properties of a second order linear differential system. Appl. Math. Inf. Sci. 9(2), 953 (2015)
Van Bezooijen, R.L., Roelen, B.A.J., Visser, A., Van Der Weepals, L., De Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S.E., Ten Dijke, P., LÃ¶wik, C.W.G.M.: Sclerostin is an osteocyteexpressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199(6), 805â€“814 (2004)
Veverka, V., Henry, A.J., Slocombe, P.M., Ventom, A., Mulloy, B., Muskett, F.W., Muzylak, M., Greenslade, K., Moore, A., Zhang, L., et al.: Characterization of the structural features and interactions of sclerostin molecular insight into a key regulator of wntmediated bone formation. J. Biol. Chem. 284(16), 10890â€“10900 (2009)
Weinbaum, S., Cowin, S.C., Zeng, Y.: A model for the excitation of osteocytes by mechanical loadinginduced bone fluid shear stresses. J. Biomech. 27(3), 339â€“360 (1994)
Whitfield, J.F.: Growing Bone. Landes Bioscience (2007)
Acknowledgements
Not applicable.
Availability of data and materials
This paper contains no any studies with human participants or animals performed by any of the authors. All the data related to the current study were provided along with this paper.
Funding
Funding was received via project NRPU 5420 and NRPU 4250.
Author information
Authors and Affiliations
Contributions
SJ conceived the paper and prepared materials and methods. MY did the analytic analysis. YB did numerical computations. AS did results and discussion. AbS did the literature review. All authors equally contributed in the final version of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that there is no conflict of interests.
Additional information
Publisherâ€™s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Javed, S., Younas, M., Bhatti, M.Y. et al. Analytic approach to explore dynamical osteoporotic bone turnover. Adv Differ Equ 2019, 61 (2019). https://doi.org/10.1186/s1366201919867
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s1366201919867